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Abstract
We sequenced the genome of a Clostridium tetani strain that
caused chronic tibial osteitis without any clinical sign of tetanus in
a 26-year-old man previously vaccinated against this disease. The
genome contained a plasmid that harboured the tetX-tetR tetano-
spasmin operon, and was highly similar to that of a tetanus-causing
strain.
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In August 2011, a 26-year-old man, vaccinated against tetanus
in 1997, was admitted to hospital in Marseille, France, for an
open fracture of his left tibia, contaminated with soil (P. Y.
Levy, unpublished data). He had specific anti-toxin antibodies
as measured using the immunochromatic test (Tetanos Quick
Stick Test, InGen, Chilly-Mazarin, France). Due to suppuration
of the wound despite surgical revision and osteosynthesis, a
bone biopsy was performed, from which Clostridium tetani
(susceptible to all tested antibiotics) was cultivated. Translu-
cent grey colonies were obtained after 4 days of incubation in
an anaerobic atmosphere on blood-enriched Columbia agar at
37°C. Production of tetanospasmin by the infecting strain was
confirmed by the French reference centre for anaerobic
bacteria by inoculation to mice. The patient did not develop
any symptoms of tetanus. Despite several prolonged antibiotic
therapies and surgical revisions, including the removal of a
tibial sequestrum, as well as the administration of a dose of
tetanus vaccine and prophylactic immunoglobulins, no tibial
consolidation could ever be obtained. Seventeen months after
the accident, the patient underwent amputation of his left leg.
In order to investigate the virulence factors carried by the
patient’s strain, notably the presence of a toxin, we sequenced
its genome.
Following DNA extraction from the patient’s strain (strain
12124569) using the phenol–chloroform method, paired-end
sequencing was performed using a 454 GS/FLX pyrosequencer
(Roche Diagnostics, Meylan, France). The sequencing gener-
ated 792 841 reads, for a total output of 142 Mb. Following
assembly, strain 12124569 had a chromosome size of
2 807 481 bp and exhibited a single 58 369 bp plasmid
(GenBank accession numbers HG530135 and HG530136,
respectively). The assembly was performed using Newbler
2.8 software (Roche). Finishing was achieved using the CLC
genomics software (http://www.clcbio.com/). Open reading
frames (ORFs) were predicted using Prodigal (http://prodigal.
ornl.gov). The predicted bacterial protein sequences were
searched against the GenBank database and the Clusters of
Orthologous Groups (COG) databases using BLASTP. The
tRNAScanSE tool [1] was used to find tRNA genes, whereas
ribosomal RNAs were found by using RNAmmer [2] and
BLASTn against GenBank.
Prior to our study, only one C. tetani genome, from
toxigenic strain E88, had been sequenced [3]. By comparison
with strain E88 (GenBank accession number NC_004557),
strain 12124569 had a chromosome of a similar size (2.8 Mb)
but a smaller plasmid (58 vs. 74 kb, respectively). Both
chromosomes were highly collinear but strain 12124569 had
a slightly higher GC content (28.7% vs. 28.6%, respectively).
Strain 12124569 had 2845 predicted protein-coding genes, five
rRNA operons, 52 tRNAs, one tmRNA, and 66 miscellaneous
other RNAs. Both C. tetani strains exhibited very similar gene
contents, and each notably had the plasmidic tetanospasmin-
coding gene tetX as well as its transcriptional regulator tetR [4].
Both tetX genes were highly similar except a few synonymous
single-nucleotide polymorphisms (SNPs). In addition, both
plasmids also carried the colT gene that predictably codes a
collagenase involved in tissue lysis [3].
Clostridium tetani is an environmental bacterium that causes
tetanus, a toxi-infection associated with a high mortality. Most
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of its pathogenesis results from the neurotoxin, also named
tetanospasmin that it produces within the body once spores
have contaminated a wound. In France, tetanus is a reportable
but rare disease because of compulsory vaccination (French
vaccine calendar 2012: http://www.sante.gouv.fr/calendri-
er-vaccinal-detaille-2012.html). Between 2008 and 2011, only
36 cases of tetanus were reported. In addition to tetanus, rare
cases of focal C. tetani infections have been described, including
a patient with humerus osteitis that resolved using antibiotics
but for whom the toxin production by the infecting strain was
not evaluated [5]; and a case of wound infection without
osteitis caused by a proven toxigenic strain. The patient in this
case readily improved after treatment with prophylactic
immunoglobulins, tetanus vaccine, and antibiotics [6]. How-
ever, the case presented here was unusual in that the patient
developed a chronic C. tetani infection caused by a toxigenic
strain that persisted despite repeated antibiotic therapies and
surgical revisions, without any clinical manifestation of tetanus.
However, the genomic analysis of the strain infecting the
patient did not reveal any difference when compared to the
toxigenic strain E88, and strain 12124569 also harboured the
tetanospasmin-coding gene tetX and was proven to be toxin-
producing. We conclude that it is likely that the vaccinal status
of the patient protected him from developing tetanus but not
from chronic C. tetani infection.
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